From: Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer
 |  | Tumors cell |  | MSC |  | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Parameters | Â | low reactivity high reactivity | P value | low reactivity high reactivity | P value | ||||||
 |  | n | % | n | % |  | n | % | n | % |  |
Agea | Â | Â | Â | Â | Â | 0.379 | Â | Â | Â | Â | 0.904 |
< 59 | 48 | 32 | 66.7 | 16 | 33.3 | Â | 26 | 54.2 | 22 | 45.8 | Â |
≥ 59 | 66 | 49 | 74.2 | 17 | 25.8 |  | 35 | 53.0 | 31 | 47.0 |  |
Gender | Â | Â | Â | Â | Â | 0.276 | Â | Â | Â | Â | 0.276 |
men | 54 | 41 | 75.9 | 13 | 24.1 | Â | 26 | 48.1 | 28 | 51.9 | Â |
women | 60 | 40 | 66.7 | 20 | 33.3 | Â | 35 | 58.3 | 25 | 41.7 | Â |
Tumor sizeb | Â | Â | Â | Â | Â | 0.222 | Â | Â | Â | Â | 0.658 |
< 5.0 | 52 | 34 | 65.4 | 18 | 34.6 | Â | 29 | 55.8 | 23 | 44.2 | Â |
≥ 5.0 | 62 | 47 | 75.8 | 15 | 24.2 |  | 32 | 51.6 | 30 | 48.4 |  |
Localization | Â | Â | Â | Â | Â | 0.140 | Â | Â | Â | Â | 0.926 |
colon ascendens | 27 | 22 | 81.5 | 5 | 18.5 | Â | 14 | 51.9 | 13 | 48.1 | Â |
flexura hepatica | 22 | 17 | 77.3 | 5 | 22.7 | Â | 12 | 54.5 | 10 | 45.5 | Â |
colon transversum | 6 | 6 | 100 | 0 | 0 | Â | 3 | 50.0 | 3 | 50.0 | Â |
flexura lienalis | 8 | 6 | 75.0 | 2 | 25.0 | Â | 3 | 37.5 | 5 | 62.5 | Â |
colon descendens | 6 | 3 | 50.0 | 3 | 50.0 | Â | 4 | 66.7 | 2 | 33.3 | Â |
colon sigmoideum | 45 | 27 | 60.0 | 18 | 40.0 | Â | 25 | 55.6 | 20 | 44.4 | Â |
Tumor differentiation | Â | Â | Â | Â | Â | 0.930 | Â | Â | Â | Â | 0.046 |
low | 16 | 12 | 75.0 | 4 | 25.0 | Â | 4 | 25.0 | 12 | 75.0 | Â |
moderate | 68 | 48 | 70.6 | 20 | 29.1 | Â | 39 | 57.4 | 29 | 42.6 | Â |
high | 30 | 21 | 70.0 | 9 | 30.0 | Â | 18 | 60.0 | 12 | 40.0 | Â |
Lymph node metastasis | Â | Â | Â | Â | Â | 0.462 | Â | Â | Â | Â | 0.013 |
N0 | 65 | 44 | 67.7 | 21 | 32.3 | Â | 28 | 43.1 | 37 | 56.9 | Â |
N1 | 36 | 26 | 72.2 | 10 | 27.8 | Â | 22 | 61.1 | 14 | 38.9 | Â |
N2 | 13 | 11 | 84.6 | 2 | 15.4 | Â | 11 | 84.6 | 2 | 15.4 | Â |
R/DMc | Â | Â | Â | Â | Â | 0.490 | Â | Â | Â | Â | 0.746 |
Yes | 23 | 15 | 65.2 | 8 | 34.8 | Â | 13 | 56.5 | 10 | 43.5 | Â |
No | 91 | 66 | 72.5 | 25 | 27.5 | Â | 48 | 52.7 | 43 | 47.3 | Â |
L/infiltrationd | Â | Â | Â | Â | Â | 0.626 | Â | Â | Â | Â | 0.678 |
Yes | 41 | 28 | 68.3 | 13 | 21.7 | Â | 23 | 56.1 | 18 | 43.9 | Â |
No | 73 | 53 | 72.6 | 20 | 27.4 | Â | 38 | 52.1 | 35 | 47.9 | Â |
depth of invasion | Â | Â | Â | Â | Â | 0.459 | Â | Â | Â | Â | 0.850 |
T2 | 15 | 12 | 80.0 | 3 | 20.0 | Â | 8 | 53.3 | 7 | 46.7 | Â |
T3 | 88 | 60 | 68.2 | 28 | 31.8 | Â | 48 | 54.5 | 40 | 45.5 | Â |
T4 | 11 | 9 | 81.8 | 2 | 18.2 | Â | 5 | 45.5 | 6 | 54.5 | Â |
Distant metastasis | Â | Â | Â | Â | Â | 0.504 | Â | Â | Â | Â | 0.797 |
M0 | 102 | 71 | 69.6 | 31 | 30.4 | Â | 55 | 53.9 | 47 | 46.1 | Â |
M1 | 12 | 10 | 83.3 | 2 | 16.7 | Â | 6 | 50.0 | 6 | 50.0 | Â |
TNM staging | Â | Â | Â | Â | Â | 0.431 | Â | Â | Â | Â | 0.297 |
I | 11 | 9 | 81.8 | 2 | 22.2 | Â | 5 | 45.5 | 6 | 54.5 | Â |
II | 47 | 30 | 63.8 | 17 | 36.2 | Â | 21 | 44.7 | 26 | 55.3 | Â |
III | 44 | 32 | 72.7 | 12 | 27.3 | Â | 28 | 63.6 | 16 | 36.4 | Â |
IV | 12 | 10 | 83.3 | 2 | 16.7 | Â | 7 | 58.3 | 5 | 41.7 | Â |